Standard Chemical & Pharmaceutical Co., Ltd. is a healthcare professional focused on the manufacturing of chemical and pharmaceutical products. The company operates through a network of subsidiaries and offices across Asia, including Standard Chem. & Pharm. Vietnam Co. Ltd., Standard Chem. & Pharm. Philippines, Inc., Standard Pharmaceutical Co., Ltd., and Standard Pharma Holding Co., Ltd. Its business activities are supported by regional offices in Ho Chi Minh City, Hanoi, Taguig, Apia, Bangkok, and Shanghai. The company emphasizes strict quality assurance systems and adherence to national and international standards in its production processes.

Summarised from the company's own disclosures, fiscal year ended Oct 2026

Industry Drug Manufacturers - General Homepage standard.com.tw
Sector Healthcare IR page standard.com.tw/investor-f-law.php
Tags
chemical manufacturing, pharmaceuticals, quality assurance, healthcare, api manufacturing, Standard Chem. & Pharm. Vietnam Co. Ltd., Standard Chem. & Pharm. Philippines Inc., Standard Pharmaceutical Co. Ltd., Standard Pharma Holding Co. Ltd.
Press page —

Metrics

Valuation  
Market cap NT$ 10.711B
Market cap (USD) $ 325.105M
P/E 10.46
PEG 2.38
P/BV 1.66
P/S 1.48
P/OCF 6.32
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 15.4%
ROI 15.1%
ROIC 18.5%
Profit margin 13.2%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 4.4%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) Yes
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 56.3%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Revenue 7.023B 6.789B 6.24B 5.851B 4.604B 4.305B 3.937B 3.573B 3.849B 3.674B 3.321B 3.296B 3.054B 3.374B 3.332B 2.894B
Net profit 927.659M 880.501M 834.886M 815.408M 706.734M 524.172M 376.482M 374.359M 363.286M 340.216M 347.894M 374.235M 298.386M 271.426M 246.748M 210.053M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Share price 58.9 61.9 65.9 61.5 43.1 37.7 — — — — — — — — — —
Price performance 12m -0.05 -0.06 0.07 0.43 0.14 — — — — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

公告本公司召開法人說明會相關資訊 Bull 0 Bear 0 Routine

Prompts

Standard Chemical & Pharmaceutical Co., Ltd. (ticker 1720.TW), listed in Taiwan.

ETFs Holding Standard Chemical & Pharmaceutical Co., Ltd.

ETF Weight in ETF Shares Market value As of
DFEV 0.00% 45,500 $ 75.765K Nov 12, 2026
DFEM 0.00% 145,200 $ 241.783K Nov 12, 2026
DFSE 0.00% 6,600 $ 10.99K Nov 12, 2026
DFAE 0.00% 97,400 $ 162.188K Nov 12, 2026
DFAX 0.00% 66,363 $ 110.506K Nov 12, 2026
AVEM 0.00% 17,600 $ 29.495K Nov 16, 2026
AVEE 0.00% 2,200 $ 3,686.86 Nov 16, 2026
AVXC 0.00% 5,200 $ 8,714.40 Nov 16, 2026